Trigent Achieves SBTi Approval for Net-Zero Emissions Targets
On Track to Cut Emissions Significantly by 2030, Strengthening Its Commitment to a Sustainable Future SOUTHBOROUGH, Mass., March 26, 2025 /PRNewswire/ — Trigent,... Read more.
Revenue Analytics Named a Best Place to Work by Built In
Leading the Future of Smarter, AI-Powered Pricing, Revenue Analytics Named a Best Place to Work ATLANTA, March 26, 2025 /PRNewswire/ — Revenue Analytics,... Read more.
Mabwell to Present results of 6 studies at the 2025 American Association for Cancer Research (AACR) Annual Meeting
SHANGHAI, March 26, 2025 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will... Read more.
AUKEY’s Cutting-Edge Bluetooth Tracker and Cooling Chargers Earn Top Honors at iF DESIGN AWARD 2025
Three of AUKEY’s latest innovations are recognized for outstanding design as the company remains dedicated to creating exceptional products that meet diverse... Read more.
NextFlex announces 2025 Fellows Awards for four outstanding recipients
SAN JOSE, Calif., March 26, 2025 /PRNewswire/ — NextFlex®, America’s hybrid electronics manufacturing institute, presented the annual NextFlex Fellow... Read more.
DeFi Technologies Announces Shareholder Call to Discuss 2024 Financial Results
TORONTO, March 26, 2025 /PRNewswire/ – (the “Company” or “DeFi Technologies“) (CBOE CA: DEFI) (GR: R9B) (OTC: DEFTF), a financial... Read more.
NetDragon Announces 2024 Annual Financial Results, Fully Embraces the World of Artificial Intelligence
Profit Before Tax Up 19% YoY Final Dividend Increased by 25% YoY to HK$0.5 Per Share HONG KONG, March 26, 2025 /PRNewswire/ — NetDragon Websoft Holdings... Read more.
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further investigation... Read more.
Mynd Announces Fiscal Year 2024 Results
Highlights Include Sale of a Non-strategic Business Unit, Significant Reduction of Debt, and Implementation of a Share Repurchase Program to Strengthen the Company... Read more.
SOF Support Foundation Accepting Applications for its 2026 Congressional Fellowship Program
SAN DIEGO, March 26, 2025 /PRNewswire/ — SOF (Special Operations Forces) Support Foundation Chair Dominique Plewes announced today that the 2026 application... Read more.